{"id":503076,"date":"2021-06-11T09:34:12","date_gmt":"2021-06-11T13:34:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/"},"modified":"2021-06-11T09:34:12","modified_gmt":"2021-06-11T13:34:12","slug":"thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/","title":{"rendered":"Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly?"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">NEW YORK<\/span>, <span class=\"xn-chron\">June 11, 2021<\/span> \/PRNewswire\/ &#8212; InvestorsObserver issues critical PriceWatch Alerts for CRSP, AMC, ATOM, PRTA, and LLY.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg\" title=\"InvestorsObserver (PRNewsfoto\/InvestorsObserver)\" alt=\"InvestorsObserver (PRNewsfoto\/InvestorsObserver)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Click a link below then choose between in-depth options trade idea report or a stock score report.<\/p>\n<p>Options Report \u2013 Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.<\/p>\n<p>Stock Report &#8211; Measures a stock&#8217;s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street&#8217;s opinion including a 12-month price forecast.<\/p>\n<ul type=\"disc\">\n<li>CRSP: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3193852-1&amp;h=158574479&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DCRSP%26prnumber%3D061120214&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DCRSP%26prnumber%3D061120214\" rel=\"nofollow noopener\">https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=CRSP&amp;prnumber=061120214<\/a><\/li>\n<li>AMC: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3193852-1&amp;h=1142715436&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DAMC%26prnumber%3D061120214&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DAMC%26prnumber%3D061120214\" rel=\"nofollow noopener\">https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=AMC&amp;prnumber=061120214<\/a><\/li>\n<li>ATOM: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3193852-1&amp;h=1092576044&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DATOM%26prnumber%3D061120214&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DATOM%26prnumber%3D061120214\" rel=\"nofollow noopener\">https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=ATOM&amp;prnumber=061120214<\/a><\/li>\n<li>PRTA: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3193852-1&amp;h=3397909763&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DPRTA%26prnumber%3D061120214&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DPRTA%26prnumber%3D061120214\" rel=\"nofollow noopener\">https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=PRTA&amp;prnumber=061120214<\/a><\/li>\n<li>LLY: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3193852-1&amp;h=2119269304&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DLLY%26prnumber%3D061120214&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DLLY%26prnumber%3D061120214\" rel=\"nofollow noopener\">https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=LLY&amp;prnumber=061120214<\/a><\/li>\n<\/ul>\n<p>(Note: You may have to copy this link into your browser then press the [ENTER] key.)<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CG08527&amp;sd=2021-06-11\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly-301310871.html\">http:\/\/www.prnewswire.com\/news-releases\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly-301310871.html<\/a><\/p>\n<p>SOURCE  InvestorsObserver<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=CG08527&amp;Transmission_Id=202106110931PR_NEWS_USPR_____CG08527&amp;DateId=20210611\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK, June 11, 2021 \/PRNewswire\/ &#8212; InvestorsObserver issues critical PriceWatch Alerts for CRSP, AMC, ATOM, PRTA, and LLY. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report \u2013 Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock. Stock Report &#8211; Measures a stock&#8217;s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street&#8217;s opinion including a 12-month price forecast. CRSP: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=CRSP&amp;prnumber=061120214 AMC: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=AMC&amp;prnumber=061120214 ATOM: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=ATOM&amp;prnumber=061120214 PRTA: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=PRTA&amp;prnumber=061120214 LLY: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=LLY&amp;prnumber=061120214 (Note: You may have to copy this link into your browser then press the [ENTER] &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly?&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-503076","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly? - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly? - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, June 11, 2021 \/PRNewswire\/ &#8212; InvestorsObserver issues critical PriceWatch Alerts for CRSP, AMC, ATOM, PRTA, and LLY. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report \u2013 Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock. Stock Report &#8211; Measures a stock&#8217;s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street&#8217;s opinion including a 12-month price forecast. CRSP: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=CRSP&amp;prnumber=061120214 AMC: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=AMC&amp;prnumber=061120214 ATOM: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=ATOM&amp;prnumber=061120214 PRTA: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=PRTA&amp;prnumber=061120214 LLY: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=LLY&amp;prnumber=061120214 (Note: You may have to copy this link into your browser then press the [ENTER] &hellip; Continue reading &quot;Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly?&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-11T13:34:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly?\",\"datePublished\":\"2021-06-11T13:34:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\\\/\"},\"wordCount\":194,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1333368\\\/InvestorsObserver_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\\\/\",\"name\":\"Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly? - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1333368\\\/InvestorsObserver_Logo.jpg\",\"datePublished\":\"2021-06-11T13:34:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1333368\\\/InvestorsObserver_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1333368\\\/InvestorsObserver_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly? - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/","og_locale":"en_US","og_type":"article","og_title":"Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly? - Market Newsdesk","og_description":"PR Newswire NEW YORK, June 11, 2021 \/PRNewswire\/ &#8212; InvestorsObserver issues critical PriceWatch Alerts for CRSP, AMC, ATOM, PRTA, and LLY. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report \u2013 Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock. Stock Report &#8211; Measures a stock&#8217;s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street&#8217;s opinion including a 12-month price forecast. CRSP: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=CRSP&amp;prnumber=061120214 AMC: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=AMC&amp;prnumber=061120214 ATOM: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=ATOM&amp;prnumber=061120214 PRTA: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=PRTA&amp;prnumber=061120214 LLY: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=LLY&amp;prnumber=061120214 (Note: You may have to copy this link into your browser then press the [ENTER] &hellip; Continue reading \"Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly?\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-11T13:34:12+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly?","datePublished":"2021-06-11T13:34:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/"},"wordCount":194,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/","name":"Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly? - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg","datePublished":"2021-06-11T13:34:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-crispr-therapeutics-amc-atomera-prothena-corp-or-eli-lilly\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly?"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/503076","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=503076"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/503076\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=503076"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=503076"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=503076"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}